Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
NMRA holding history
Neumora Therapeutics, Inc. in every 13F filed by Johnson & Johnson, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NMRA overviewAll 13F holders of NMRAFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,849,445
- Value
- $3.14M
- % of portfolio
- 0.4%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,849,445 | $3.14M | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,849,445 | $3.61M | 0.6% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,849,445 | $3.31M | 0.6% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,849,445 | $3.37M | 0.7% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1,849,445 | $1.40M | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1,849,445 | $1.85M | 0.5% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1,849,445 | $19.6M | 5.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1,849,445 | $24.4M | 5.7% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,849,445 | $18.2M | 4.5% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,849,445 | $25.4M | 0.6% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1,849,445 | $31.5M | 0.7% | +937,317+102.8% | Added | Holders |
| Q3 2023 | 912,128 | $12.9M | 4.7% | +912,128 | New | Holders |